Valuation: Biogen Inc.

Market Cap 3.04TCr 2.66TCr 2.45TCr 2.27TCr 4.31TCr 2,88200Cr 4.38TCr 29TCr 11TCr 1,42200Cr 11TCr 11TCr 4,91700Cr P/E 2026 *
31.3x
P/E 2027 * 17.2x
Enterprise Value 3.59TCr 3.14TCr 2.89TCr 2.68TCr 5.09TCr 3,40500Cr 5.17TCr 35TCr 13TCr 1,68000Cr 13TCr 13TCr 5,80800Cr EV / Sales 2026 *
3.57x
EV / Sales 2027 * 3.25x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.11%
1 week-4.79%
Current month-4.79%
1 month+5.30%
3 months+17.13%
6 months+10.05%
Current year+16.88%
1 week 205.65
Extreme 205.65
219.02
1 month 193.2
Extreme 193.195
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
282.74
5 years 110.04
Extreme 110.035
372.12
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
09/06Free

Chairman

2,005 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-4.79%+58.07%-25.22% 3.04TCr
-1.77%+8.45%+25.67%-2.34% 6.88TCr
-1.42%-3.10%+46.91%+218.59% 5.52TCr
+1.21%+42.20%+42.20%+42.20% 4.35TCr
+0.27%+8.33%-49.87%-53.43% 4.12TCr
-4.71%+13.91%+166.79%-32.89% 3.17TCr
-1.07%+4.14%+75.49%+90.19% 2.36TCr
-1.15%+8.29%+4.42%+184.96% 1.93TCr
-1.31%+2.51%+65.59%+132.84% 1.72TCr
-0.69%+4.61%+79.10%+361.28% 1.53TCr
Average -1.17%+4.32%+51.44%+91.62% 3.46TCr
Weighted average by Cap. -1.15%+4.21%+44.45%+67.15%

Financials

2026 *2027 *
Net sales 1.01TCr 879.51Cr 810.56Cr 751.29Cr 1.43TCr 95TCr 1.45TCr 9.72TCr 3.78TCr 47TCr 3.77TCr 3.69TCr 1,62700Cr 1.04TCr 908.81Cr 837.56Cr 776.32Cr 1.47TCr 99TCr 1.5TCr 10TCr 3.91TCr 49TCr 3.9TCr 3.81TCr 1,68100Cr
Net income 152.22Cr 133.21Cr 122.76Cr 113.79Cr 216.01Cr 14TCr 219.49Cr 1.47TCr 572.46Cr 7.13TCr 571.48Cr 559.11Cr 25TCr 196.89Cr 172.3Cr 158.79Cr 147.18Cr 279.39Cr 19TCr 283.89Cr 1.9TCr 740.44Cr 9.22TCr 739.18Cr 723.17Cr 32TCr
Net Debt 550.87Cr 482.07Cr 444.27Cr 411.79Cr 781.71Cr 52TCr 794.31Cr 5.33TCr 2.07TCr 26TCr 2.07TCr 2.02TCr 89TCr 338.49Cr 296.21Cr 272.99Cr 253.03Cr 480.33Cr 32TCr 488.07Cr 3.27TCr 1.27TCr 16TCr 1.27TCr 1.24TCr 55TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
08/26/08 $205.70 -1.32% 11,56,880
06/26/06 $208.46 -3.54% 12,18,492
02/26/02 $216.12 +3.04% 11,55,165
01/26/01 $209.74 -2.93% 11,38,639
30/26/30 $216.06 -0.26% 10,91,325
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
205.70USD
Average target price
222.38USD
Spread / Average Target
+8.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock